Dr.Yong Gao (China)
Chief Oncology Specialist

Prof Gao a doctoral supervisor at Tongji University in Shanghai and Nanjing Medical University. He has been engaged in clinical diagnosis and treatment of tumors for more than 30 years, and is good at multi-disciplinary diagnosis and treatment of gastric cancer, intestinal cancer, lung cancer and breast cancer, as well as tumor cell immunotherapy, and liver metastasis. He is keen on tumor target detection, analysis, target interpretation and therapy.

He was as a visiting associate professor at MD Anderson Cancer Center in the United States from 2007 to 2009. He is now a member of CSCO Pancreatic Cancer Professional Committee of the Chinese Society of Clinical Oncology, a senior member of ASCO of the American Society of Clinical Oncology, a member of Shanghai Medical Association Cancer Society, of the Palliative Treatment Professional Committee of the Chinese Medical Association, and of Shanghai Medical Association Cancer Society.

He has led national level projects, published research papers in internationally renowned journals such as Cancer Research, Gastroenterology, Clinical Cancer Research, as well as dozens of papers in domestic core journals. His oncology department was awarded the Key Specialty Unit in Shanghai in 2012.

Dr.Yanwei Shen (China)
Physician

Dr. Shen graduated from Zhejiang University School of Medicine, with an MD degree in Clinical Oncology, and further won PhD degree in Oncologic Immunology jointly certified by his Uni and the Center for Gene and Cell Therapy, Baylor College of Medicine.

With a strong background of translational study experience of autologous immune cell transfer therapy for cancer treatment, Dr. Shen also has expertise in tumor immunotherapy, and has long been engaged in front-line clinical work and clinical translational research in tumor radiotherapy, chemotherapy and biological therapy, especially in the diagnosis and treatment of colorectal cancer, lung cancer, breast cancer, gynecological cancers et al. As an immunologist, Dr. Shen also leads a research team specializing in neoantigen immune-enhancing therapy and autologous immune cell transfer therapy for the management of chronic cancerous diseases.

He was granted Biosafety Laboratory level 2 (BSL-2) specialist, Abbott Holistic Nutritional Therapist, Member of the Chinese Society for Immunology (CSI), Member of Chinese Society of Clinical Oncology (CSCO), Board member of the 6th Board of Directors of China-Japan Medical Science and Technology Exchange Association (CJMST).

His working languages are Madarin, English and Japanese.